WHA Member States Approve Antimicrobial Resistance Strategy After Resolving Tech Transfer Debate 23/05/2026 Stefan Anderson WHO Member States approved a new 10-year global action plan to combat antimicrobial resistance (AMR) on Friday after a months-long fight over how the world should share AMR-related medical technologies. The plan, which runs through 2036, maps out strategies for countries to implementing the ambitious targets set at a UN High Level Meeting, including reducing […] Continue reading -> Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Making Better Vaccine Choices in a Shifting Global Health Landscape 27/04/2026 Charlie Weller In an era of big global health budget cuts that often demand tough choices, identifying vaccine needs and priorities at national level is increasingly important. As we observe World Immunization Week, it’s time to recognize the pivotal role that National Immunization Technical Advisory Groups (NITAGs) can play in guiding effective, evidence-based decisions – alongside global […] Continue reading -> Congress Presses RFK Jr on Whether New CDC Chief Can Act Independently on Vaccines 24/04/2026 Sophia Samantaroy US Health and Human Services Secretary Robert F Kennedy Jr offered contradictory responses that the country’s new leader of the Centers for Disease Control and Prevention (CDC) would be able to make decisions independent of political interference, especially around vaccines. The White House announced late last week its fourth pick in a year for CDC director, […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Making Better Vaccine Choices in a Shifting Global Health Landscape 27/04/2026 Charlie Weller In an era of big global health budget cuts that often demand tough choices, identifying vaccine needs and priorities at national level is increasingly important. As we observe World Immunization Week, it’s time to recognize the pivotal role that National Immunization Technical Advisory Groups (NITAGs) can play in guiding effective, evidence-based decisions – alongside global […] Continue reading -> Congress Presses RFK Jr on Whether New CDC Chief Can Act Independently on Vaccines 24/04/2026 Sophia Samantaroy US Health and Human Services Secretary Robert F Kennedy Jr offered contradictory responses that the country’s new leader of the Centers for Disease Control and Prevention (CDC) would be able to make decisions independent of political interference, especially around vaccines. The White House announced late last week its fourth pick in a year for CDC director, […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Making Better Vaccine Choices in a Shifting Global Health Landscape 27/04/2026 Charlie Weller In an era of big global health budget cuts that often demand tough choices, identifying vaccine needs and priorities at national level is increasingly important. As we observe World Immunization Week, it’s time to recognize the pivotal role that National Immunization Technical Advisory Groups (NITAGs) can play in guiding effective, evidence-based decisions – alongside global […] Continue reading -> Congress Presses RFK Jr on Whether New CDC Chief Can Act Independently on Vaccines 24/04/2026 Sophia Samantaroy US Health and Human Services Secretary Robert F Kennedy Jr offered contradictory responses that the country’s new leader of the Centers for Disease Control and Prevention (CDC) would be able to make decisions independent of political interference, especially around vaccines. The White House announced late last week its fourth pick in a year for CDC director, […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Making Better Vaccine Choices in a Shifting Global Health Landscape 27/04/2026 Charlie Weller In an era of big global health budget cuts that often demand tough choices, identifying vaccine needs and priorities at national level is increasingly important. As we observe World Immunization Week, it’s time to recognize the pivotal role that National Immunization Technical Advisory Groups (NITAGs) can play in guiding effective, evidence-based decisions – alongside global […] Continue reading -> Congress Presses RFK Jr on Whether New CDC Chief Can Act Independently on Vaccines 24/04/2026 Sophia Samantaroy US Health and Human Services Secretary Robert F Kennedy Jr offered contradictory responses that the country’s new leader of the Centers for Disease Control and Prevention (CDC) would be able to make decisions independent of political interference, especially around vaccines. The White House announced late last week its fourth pick in a year for CDC director, […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
Making Better Vaccine Choices in a Shifting Global Health Landscape 27/04/2026 Charlie Weller In an era of big global health budget cuts that often demand tough choices, identifying vaccine needs and priorities at national level is increasingly important. As we observe World Immunization Week, it’s time to recognize the pivotal role that National Immunization Technical Advisory Groups (NITAGs) can play in guiding effective, evidence-based decisions – alongside global […] Continue reading -> Congress Presses RFK Jr on Whether New CDC Chief Can Act Independently on Vaccines 24/04/2026 Sophia Samantaroy US Health and Human Services Secretary Robert F Kennedy Jr offered contradictory responses that the country’s new leader of the Centers for Disease Control and Prevention (CDC) would be able to make decisions independent of political interference, especially around vaccines. The White House announced late last week its fourth pick in a year for CDC director, […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
Congress Presses RFK Jr on Whether New CDC Chief Can Act Independently on Vaccines 24/04/2026 Sophia Samantaroy US Health and Human Services Secretary Robert F Kennedy Jr offered contradictory responses that the country’s new leader of the Centers for Disease Control and Prevention (CDC) would be able to make decisions independent of political interference, especially around vaccines. The White House announced late last week its fourth pick in a year for CDC director, […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts
Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Posts navigation Older posts